PubRank

Lauri Toivonen

Author PubWeight™ 94.32‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med 2011 8.93
2 The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study. Circulation 2013 2.64
3 Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation 2004 2.63
4 The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome. Circulation 2006 2.58
5 Further evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug-associated torsades de pointes. Heart Rhythm 2007 1.93
6 Mutant ryanodine receptors in catecholaminergic polymorphic ventricular tachycardia generate delayed afterdepolarizations due to increased propensity to Ca2+ waves. Eur Heart J 2007 1.83
7 A novel mutation, Ser143Pro, in the lamin A/C gene is common in finnish patients with familial dilated cardiomyopathy. Eur Heart J 2004 1.78
8 Short-term implantation-related complications of cardiac rhythm management device therapy: a retrospective single-centre 1-year survey. Europace 2010 1.76
9 Predictive value of electrocardiographic QT interval and T-wave morphology parameters for all-cause and cardiovascular mortality in a general population sample. Heart Rhythm 2009 1.68
10 Population-prevalent desmosomal mutations predisposing to arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm 2011 1.62
11 U-waves and T-wave peak to T-wave end intervals in patients with catecholaminergic polymorphic ventricular tachycardia, effects of beta-blockers. Heart Rhythm 2008 1.59
12 Relationship of common candidate gene variants to electrocardiographic T-wave peak to T-wave end interval and T-wave morphology parameters. Heart Rhythm 2010 1.58
13 Increased intra-QRS fragmentation in magnetocardiography as a predictor of arrhythmic events and mortality in patients with cardiac dysfunction after myocardial infarction. J Cardiovasc Electrophysiol 2006 1.49
14 Quality of emergency room care for atrial fibrillation. Scand Cardiovasc J 2006 1.41
15 The effect of antihistamine cetirizine on ventricular repolarization in congenital long QT syndrome. J Cardiovasc Electrophysiol 2007 1.40
16 Magnetocardiographic indices of left ventricular hypertrophy. J Hypertens 2002 1.38
17 Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry. Circulation 2010 1.38
18 Four potassium channel mutations account for 73% of the genetic spectrum underlying long-QT syndrome (LQTS) and provide evidence for a strong founder effect in Finland. Ann Med 2004 1.28
19 QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 2004 1.25
20 Catecholaminergic polymorphic ventricular tachycardia: recent mechanistic insights. Cardiovasc Res 2005 1.23
21 Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint. Am J Hypertens 2002 1.21
22 Cell model of catecholaminergic polymorphic ventricular tachycardia reveals early and delayed afterdepolarizations. PLoS One 2012 1.19
23 Electrocardiographic strain pattern and prediction of cardiovascular morbidity and mortality in hypertensive patients. Hypertension 2004 1.12
24 Functional characterization of the common amino acid 897 polymorphism of the cardiac potassium channel KCNH2 (HERG). Cardiovasc Res 2003 1.09
25 High prevalence of four long QT syndrome founder mutations in the Finnish population. Ann Med 2009 1.08
26 Electrocardiographic ventricular repolarization during cardiovascular autonomic function testing in patients with arrhythmogenic right ventricular cardiomyopathy. Scand Cardiovasc J 2008 1.07
27 Search for cardiac calcium cycling gene mutations in familial ventricular arrhythmias resembling catecholaminergic polymorphic ventricular tachycardia. BMC Med Genet 2009 1.06
28 Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations. J Cardiovasc Electrophysiol 2005 1.04
29 Two novel mutations in the beta-myosin heavy chain gene associated with dilated cardiomyopathy. Eur J Heart Fail 2004 1.03
30 Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome. Circ Cardiovasc Genet 2013 1.03
31 Fragmented QRS in prediction of cardiac deaths and heart failure hospitalizations after myocardial infarction. Ann Noninvasive Electrocardiol 2010 1.02
32 Electrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study. Circulation 2005 1.00
33 QRS duration predicts sudden cardiac death in hypertensive patients undergoing intensive medical therapy: the LIFE study. Eur Heart J 2009 1.00
34 Plakophilin-2 missense mutations in arrhythmogenic right ventricular cardiomyopathy. Int J Cardiol 2007 0.97
35 Interference of low frequency magnetic fields with implantable cardioverter-defibrillators. Scand Cardiovasc J 2012 0.95
36 Ambulatory electrocardiographic evidence of transmural dispersion of repolarization in patients with long-QT syndrome type 1 and 2. Circulation 2002 0.95
37 Relationship of electrocardiographic repolarization measures to echocardiographic left ventricular mass in men with hypertension. J Hypertens 2007 0.94
38 A novel mutation, Arg71Thr, in the delta-sarcoglycan gene is associated with dilated cardiomyopathy. J Mol Med (Berl) 2003 0.92
39 Electromagnetic interference with cardiac pacemakers and implantable cardioverter-defibrillators from low-frequency electromagnetic fields in vivo. Europace 2012 0.89
40 Increased QT dispersion and loss of sinus rhythm as risk factors for late sudden death after Mustard or Senning procedures for transposition of the great arteries. Am J Cardiol 2004 0.89
41 Effects of beta-blocker therapy on ventricular repolarization documented by 24-h electrocardiography in patients with type 1 long-QT syndrome. J Am Coll Cardiol 2006 0.87
42 Features of ST segment and T-wave in exercise-induced myocardial ischemia evaluated with multichannel magnetocardiography. Ann Med 2002 0.86
43 Genetics of hypertrophic cardiomyopathy in eastern Finland: few founder mutations with benign or intermediary phenotypes. Ann Med 2004 0.86
44 Predictive value of electrocardiographic T-wave morphology parameters and T-wave peak to T-wave end interval for sudden cardiac death in the general population. Circ Arrhythm Electrophysiol 2013 0.86
45 Ryanodine receptor (RyR2) mutations in sudden cardiac death: studies in extended pedigrees and phenotypic characterization in vitro. Int J Cardiol 2009 0.85
46 Ratio of late to early T-wave peak amplitude in 24-h electrocardiographic recordings as indicator of symptom history in patients with long-QT Syndrome types 1 and 2. J Am Coll Cardiol 2005 0.85
47 Reproducibility of computerized measurements of QT interval from multiple leads at rest and during exercise. Ann Noninvasive Electrocardiol 2006 0.85
48 Interatrial right-to-left conduction in patients with paroxysmal atrial fibrillation. J Interv Card Electrophysiol 2009 0.83
49 Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE). Circulation 2009 0.83
50 Interatrial conduction can be accurately determined using standard 12-lead electrocardiography: validation of P-wave morphology using electroanatomic mapping in man. Heart Rhythm 2007 0.82
51 Beta1-adrenergic receptor polymorphisms, QTc interval and occurrence of symptoms in type 1 of long QT syndrome. Int J Cardiol 2006 0.82
52 Relation of twelve-lead electrocardiographic T-wave morphology descriptors to left ventricular mass. Am J Cardiol 2002 0.82
53 Experimental study on malfunction of pacemakers due to exposure to different external magnetic fields. J Interv Card Electrophysiol 2012 0.82
54 Ventricular repolarization and heart rate responses during cardiovascular autonomic function testing in LQT1 subtype of long QT syndrome. Pacing Clin Electrophysiol 2006 0.82
55 Localization of prior myocardial infarction by repolarization variables. Int J Cardiol 2007 0.82
56 Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan Intervention For Endpoint Reduction (LIFE) study. Am Heart J 2003 0.81
57 Differentiation between LQT1 and LQT2 patients and unaffected subjects using 24-hour electrocardiographic recordings. Am J Cardiol 2002 0.81
58 Relation of magnetocardiographic arrhythmia risk parameters to delayed ventricular conduction in postinfarction ventricular tachycardia. Pacing Clin Electrophysiol 2002 0.81
59 Electrocardiographic interventricular dispersion of repolarization during autonomic adaptation in LQT1 subtype of long QT syndrome. Scand Cardiovasc J 2008 0.80
60 Combination of the electrocardiographic strain pattern and albuminuria for the prediction of new-onset heart failure in hypertensive patients: the LIFE study. Am J Hypertens 2008 0.80
61 Abnormal repolarization dynamics revealed in exercise test in long QT syndrome mutation carriers with normal resting QT interval. Europace 2010 0.79
62 ST-T integral and T-wave amplitude in detection of exercise-induced myocardial ischemia evaluated with body surface potential mapping. J Electrocardiol 2003 0.79
63 QRS duration in high-resolution methods and standard ECG in risk assessment after first and recurrent myocardial infarctions. Pacing Clin Electrophysiol 2006 0.79
64 Morphological analysis of sinus and retrograde atrial waves detected through a permanent pacemaker atrial lead. J Interv Card Electrophysiol 2010 0.78
65 Intravenous epinephrine infusion test in diagnosis of catecholaminergic polymorphic ventricular tachycardia. J Cardiovasc Electrophysiol 2011 0.78
66 The calcium sensitizer levosimendan and cardiac arrhythmias: an analysis of the safety database of heart failure treatment studies. Scand Cardiovasc J 2004 0.78
67 Effect of physical training on ventricular repolarization in type 1 long QT syndrome: a pilot study in asymptomatic carriers of the G589D KCNQ1 mutation. Europace 2006 0.78
68 A common variant near the KCNJ2 gene is associated with T-peak to T-end interval. Heart Rhythm 2012 0.78
69 Genes, exercise and sudden death: molecular basis of familial catecholaminergic polymorphic ventricular tachycardia. Ann Med 2004 0.78
70 Polymorphisms associated with ventricular tachyarrhythmias: rationale, design, and endpoints of the 'diagnostic data influence on disease management and relation of genomics to ventricular tachyarrhythmias in implantable cardioverter/defibrillator patients (DISCOVERY)' study. Europace 2010 0.78
71 Characteristics of atrial fibrillation and comorbidities in familial atrial fibrillation. J Cardiovasc Electrophysiol 2013 0.78
72 Short-term electrophysiological effects of losartan, bisoprolol, amlodipine, and hydrochlorothiazide in hypertensive men. Ann Med 2009 0.78
73 High-resolution signal-averaged analysis of atrial electromagnetic characteristics in patients with paroxysmal lone atrial fibrillation. Ann Noninvasive Electrocardiol 2008 0.78
74 Comparison of QT peak and QT end interval responses to autonomic adaptation in asymptomatic LQT1 mutation carriers. Clin Physiol Funct Imaging 2010 0.77
75 Dynamic QT/RR relationship in post-myocardial infarction patients with and without cardiac arrest. Scand Cardiovasc J 2010 0.77
76 Serial assessment of the electrocardiographic strain pattern for prediction of new-onset heart failure during antihypertensive treatment: the LIFE study. Eur J Heart Fail 2011 0.77
77 Epinephrine bolus test in detecting long QT syndrome mutation carriers with indeterminable electrocardiographic phenotype. Ann Noninvasive Electrocardiol 2011 0.77
78 Tissue Doppler strain-mapping in the assessment of the extent of chronic myocardial infarction: validation using magnetic resonance imaging. Eur J Echocardiogr 2008 0.77
79 Effects of epinephrine on right ventricular monophasic action potentials in the LQT1 versus LQT2 form of long QT syndrome: preferential enhancement of "triangulation" in LQT1. Pacing Clin Electrophysiol 2005 0.76
80 Non-invasive detection of conduction pathways to left atrium using magnetocardiography: validation by intra-cardiac electroanatomic mapping. Europace 2008 0.76
81 Changing capacity of electrocardiographic ventricular repolarization in post-myocardial infarction patients with and without nonfatal cardiac arrest. Am J Cardiol 2006 0.76
82 Interatrial conduction in patients with paroxysmal atrial fibrillation and in healthy subjects. Int J Cardiol 2009 0.76
83 Testing of common electromagnetic environments for risk of interference with cardiac pacemaker function. Saf Health Work 2013 0.75
84 The atrial fibrillation epidemic is approaching the physician's door: will mobile technology improve detection? BMC Med 2014 0.75
85 Atrial refractoriness and action potential duration after sudden reversal of atrioventricular sequence. Pacing Clin Electrophysiol 2004 0.75
86 Temporal analysis of the depolarization wave of healed myocardial infarction in body surface potential mapping. Ann Noninvasive Electrocardiol 2004 0.75
87 Stress proneness in molecularly defined long QT syndrome: a study using temperament assessment by behavioural inhibition system scale. Stress Health 2012 0.75
88 Complex T-wave morphology in body surface potential mapping in prediction of arrhythmic events in patients with acute myocardial infarction and cardiac dysfunction. Europace 2009 0.75
89 [Treatment of atrial fibrillation with the means of linear ablation during cardiac surgery]. Duodecim 2003 0.75
90 Depressive symptoms in the congenital long QT syndrome. Ann Med 2009 0.75
91 [Chronic back pain, hepatomegaly and dyspnea]. Duodecim 2010 0.75
92 Cloninger's temperament traits and inherited long QT syndrome. J Psychosom Res 2011 0.75
93 Magnetocardiographic assessment of healed myocardial infarction. Ann Noninvasive Electrocardiol 2006 0.75
94 Spatial repolarization abnormalities in old myocardial infarction. J Electrocardiol 2005 0.75
95 Volatile anesthetics and succinylcholine in cardiac ryanodine receptor defects. Anesth Analg 2004 0.75
96 [Atrial fibrillation]. Duodecim 2005 0.75
97 U wave features in body surface potential mapping in post-myocardial infarction patients. Ann Noninvasive Electrocardiol 2013 0.75
98 Predicting recovery of myocardial function by electrocardiography after acute infarction. Ann Noninvasive Electrocardiol 2012 0.75
99 Late QRS activity in signal-averaged magnetocardiography, body surface potential mapping, and orthogonal ECG in postinfarction ventricular tachycardia patients. Ann Noninvasive Electrocardiol 2002 0.75
100 [Modern pacemaker therapy]. Duodecim 2010 0.75
101 Minimizing ventricular pacing by a novel atrioventricular (AV) delay hysteresis algorithm in patients with intact or compromised intrinsic AV conduction and different atrial and ventricular lead locations. Ann Med 2013 0.75
102 Measurement and reproducibility of magnetocardiographic filtered atrial signal in patients with paroxysmal lone atrial fibrillation and in healthy subjects. J Electrocardiol 2005 0.75
103 Performance of atrial tachyarrhythmia-sensing algorithms in dual-chamber pacing using a fixed long AV delay in patients with sinus node dysfunction. J Interv Card Electrophysiol 2012 0.75
104 Baseline reconstruction for localization of rapid ventricular tachycardia from body surface potential maps. Physiol Meas 2003 0.75
105 Can strain rate imaging predict recovery of contraction after acute myocardial infarction? Eur J Echocardiogr 2011 0.75
106 Reversal of atrial remodeling after cardioversion of persistent atrial fibrillation measured with magnetocardiography. Pacing Clin Electrophysiol 2009 0.75
107 Spatiotemporal characterization of paced cardiac activation with body surface potential mapping and self-organizing maps. Physiol Meas 2003 0.75
108 [Psychotropic drugs and the risk of arrhythmias]. Duodecim 2002 0.75
109 Electrocardiographic inverse problem: spatial characterization of the left ventricle potential. Conf Proc IEEE Eng Med Biol Soc 2009 0.75
110 Single-lead electrocardiographic variables in the detection of prior myocardial infarction with respect to Q-wave status and infarct age. Cardiology 2007 0.75
111 Characterization of familial and sporadic arrhythmogenic right ventricular cardiomyopathy in Finland. Ann Med 2007 0.75
112 [Is cardioversion always needed in atrial fibrillation?]. Duodecim 2003 0.75